Detalhe da pesquisa
1.
Structural changes in the retina and serum HMGB1 levels are associated with decreased cognitive function in patients with Parkinson's disease.
Neurobiol Dis;
190: 106379, 2024 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38104911
2.
Clinical findings of hyperechoic substantia nigra in patients with Parkinson's disease.
Eur J Neurosci;
59(10): 2702-2714, 2024 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38469656
3.
Increased plasma lipocalin-2 levels are associated with nonmotor symptoms and neuroimaging features in patients with Parkinson's disease.
J Neurosci Res;
102(2): e25303, 2024 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38361408
4.
Diagnostic value of plasma SIRT1 levels and whole-brain gray matter volume in Parkinson's disease patients with cognitive impairment.
Neurol Sci;
45(1): 47-54, 2024 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37718350
5.
Relationship of irisin with disease severity and dopamine uptake in Parkinson's disease patients.
Neuroimage Clin;
41: 103555, 2024.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38134742